Evidence-Based Medicine Guidelines
Intravesical bacillus Calmette-Guerin versus mitomycin C for bladder cancer.
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Intravesical Bacillus Calmette-Guerin Versus Mitomycin C for Bladder Cancer. ." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/454099/all/_________Intravesical_bacillus_Calmette_Guerin_versus_mitomycin_C_for_bladder_cancer_______.
Intravesical bacillus Calmette-Guerin versus mitomycin C for bladder cancer. . Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/454099/all/_________Intravesical_bacillus_Calmette_Guerin_versus_mitomycin_C_for_bladder_cancer_______. Accessed April 18, 2025.
Intravesical bacillus Calmette-Guerin versus mitomycin C for bladder cancer. . (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/454099/all/_________Intravesical_bacillus_Calmette_Guerin_versus_mitomycin_C_for_bladder_cancer_______
Intravesical Bacillus Calmette-Guerin Versus Mitomycin C for Bladder Cancer [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 April 18]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/454099/all/_________Intravesical_bacillus_Calmette_Guerin_versus_mitomycin_C_for_bladder_cancer_______.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Intravesical bacillus Calmette-Guerin versus mitomycin C for bladder cancer.
ID - 454099
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/454099/all/_________Intravesical_bacillus_Calmette_Guerin_versus_mitomycin_C_for_bladder_cancer_______
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
